Waldenstrom Macroglobulinemia
About the Disease
Lymphoplasmacytic Lymphoma, also known as waldenstr?m macroglobulinaemia without mention of remission, is related to macroglobulinemia and waldenstroem's macroglobulinemia. An important gene associated with Lymphoplasmacytic Lymphoma is PAX5 (Paired Box 5), and among its related pathways/superpathways are Innate Immune System and Disease. The drugs Thalidomide and Chlorambucil have been mentioned in the context of this disorder. Affiliated tissues include b cells, bone marrow and t cells, and related phenotypes are homeostasis/metabolism and cellular
Common Targets
G54715 | G7124 | G5693 | G3630 | G9439 | P12327 | G613 | G3932 | G598 | G56143 | G94025 | G4133 | G3059 | G10062 | Ephrin Receptor (nonspecified subtype) | G660 | G6850 | G64084 | G102724428 | G406947 | G8295 | G836 | G10673 | G203259 | G952 | G7157 | G4762 | G85377 | P6058 | G8654 | G51135 | G5156 | G54106 | G931 | G100 | P16964 | G3815 | Adenosine deaminase (nonspecified subtype) | G3036 | G780 | P12328 | G11184 | P13024 | G2051 | G640 | Histone deacetylase (nonspecified subtype) | G6885 | G51185 | G5579 | G970 | G9215 | G23235 | G4067 | G55954 | Janus Kinase (nonspecified subtype) | G2274 | G596 | G2444 | G25 | G1794 | G11074 | G4853 | G10514 | G54014 | G8289 | G608 | G2534 | G150094 | G930 | G10164 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | G51284 | P5859 | G5159 | G1436 | G695 | G2475 | G1991 | G6714 | G5290 | G55770 | G5243 | G5897 | G51311 | G7805 | P16091 | G7525 | G3055 | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | G1445 | G5293 | G4615 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | G2268 | G1454 | G4921 | G9429 | G2280 | G7852
The "Target / Biomarker Review Report" is a comprehensive and customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about the Target(s) / Biomarker(s) of your choice related to Waldenstrom Macroglobulinemia, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
Other Diseases
Walker-Warburg Syndrome | Warsaw Breakage Syndrome | Weill-Marchesani Syndrome | Werner's Syndrome | Whipple's Disease | Wieacker-Wolff Syndrome | Wiedemann-Steiner Syndrome | Williams Syndrome | Wilson's Disease | Wiskott-Aldrich Syndrome | Withdrawal Syndrome | Wolcott-Rallison Syndrome | Wolff-Parkinson-White Syndrome | Wolfram Syndrome | Wolfram Syndrome 2 | Wolman Disease | Woodhouse-Sakati Syndrome | X-linked Acrogigantism | X-linked Charcot-Marie-Tooth Disease | X-linked Creatine Transporter Deficiency | X-linked Myotubular Myopathy | X-linked Sideroblastic Anemia | Xeroderma Pigmentosum | Xeroderma Pigmentosum Variant Type | Yellow Fever | Zellweger Syndrome | Zimmermann-Laband Syndrome | Zollinger-Ellison Syndrome | Zygomycosis
